Stay updated with breaking news from Martin Pieprzyk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LevitasBio, Inc. (www.levitasbio.com), a premier end-to-end sample processing and cellular analysis provider to the life sciences market, unveils a suite of LeviSelect™ cell depletion and enrichment kits for immunology research.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
A new era in sample processing and characterization
A new era in sample processing and characterization
/PRNewswire/ -- LevitasBio, Inc. today unveiled the LeviCell™ EOS System, their next generation solution for cell separation and enrichment, featuring higher...